Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: A novel pathway involving α4β1 integrin receptors on sickle reticulocytes and fibronectin

Blood

Volumn 88, Issue 11, 1996, Pages 4348-4358

  Kumar, Anjali ^b   Eckmam, James R ^b   Swerlick, Robert A ^b   Wick, Timothy M ^a  

^a Georgia Institute of Technology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; IMMUNOGLOBULIN G1; INTEGRIN; INTERLEUKIN 8; PHORBOL DIBUTYRATE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE ADHESIVENESS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; RETICULOCYTE; SHEAR STRESS; SICKLE CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029957666     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4348.bloodjournal88114348     Document Type: Article

References (90)

1. Eaton WA, Hofrichter J, Ross PD: Delay time of gelation. A possible determinant of clinical severity in sickle cell disease. Blood 47:621, 1976
2. Hoover R, Rubin R, Wise G, Warren R: Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 54:872, 1979
3. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion. J Clin Invest 65:154, 1980
4. Kaul DK, Nagel RL: Sickle cell vaso-occlusion: Many issues and some answers. Experientia 49:5, 1993
5. Hebbel RP, Moldow CF, Steinberg MH: Modulation of erythrocyte- endothelial interactions and the vaso-occlusive severity of sickling disorders. Blood 58:947, 1981
6. Hebbel RP, Eaton JW, Steinberg MH, White JG: Erythrocyte/endothelial interactions in the pathogenesis of sickle cell disease: A "real logical" assessment. Blood Cells 8:163, 1982
7. Mohandas N, Evans EA: Adherence of sickle erythrocytes to vascular endothelial cells. Requirement of both cell membrane changes and plasma factors. Blood 64:282, 1984
8. Mohandas N, Evans EA: Sickle erythrocyte adherence to endothelium. Morphologic correlates and the requirement for divalent cations and collagen- binding plasma proteins. J Clin Invest 76:1605, 1985
9. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden MM: Endothelial cell interaction with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
10. Brittain HA, Eckman JR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 19:538, 1992
11. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, Mclntire LV: Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 80:905, 1987
12. Wick TM, Moake JL, Udden MM, McIntire LV: Unusually large von Willebrand factor multimers preferentially promote young sickle and non-sickle erythrocyte adhesion to endothelial cells. Am J Hematol 42:284, 1993
13. Sugihara K, Sugihara T, Mohandas N, Hebbel RP: Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood 80:2634, 1992
14. Brittain HA, Eckman JR, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion. Blood 81:2137, 1993
15. Wautier JL, Pintigny D, Wautier MP, Paton RC, Galacteros F, Passa P, Caen JP: Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. J Lab Clin Med 101:911, 1983
16. 1-integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82:1891, 1993
17. Gee BE, Platt OS: Sickle reticulocytes adhere to VCAM-1. Blood 85:268, 1995
18. Natarajan M, Udden MM, McIntire LV: Adhesion of sickle cells and damage to IL-1β stimulated endothelial cells under flow conditions in vitro. Blood 87:4845, 1996
19. 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82:3548, 1993
20. Hemler ME, Elices MJ, Parker C, Takada Y: Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 114:45, 1990
21. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R: Direct cloning of vascular cell adhesion molecule-1, a cytokine induced endothelial protein that binds to lymphocytes. Cell 59:1203, 1989
22. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577, 1990
23. Wayner EA, Garcia-Pardo A, Humphries MJ, MacDonald JA, Carter WG: Identification and characterization of the lymphocyte adhesion receptor for an alternative cell attachment domain in plasma fibronectin. J Cell Biol 109:1321, 1989
24. Garcia-Pardo A, Wayner EA, Carter WG, Ferreira OC: Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. J Immunol 144:3361, 1990
25. 1. Cell 60:53, 1990
26. Campanero MR, Pulido R, Ursa MA, Rodriguez-Moya M, de Landazuri MO, Sanchez-Madrid F: An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin. J Cell Biol 110:2157, 1990
27. Bednarczyk JL, McIntyre BW: A monoclonal antibody to VLA-4 alpha-chain (CDw49d) induces homotypic lymphocyte aggregation. J Immunol 144:777, 1990
28. Pulido R, Elices MJ, Campanero MR, Osborn L, Schiffer S, Garcia-Pardo A, Lobb R, Hemler ME, Sanchez-Madrid F: Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J Biol Chem 266:10241, 1991
29. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
30. Masumoto A, Hemler ME: Multiple activation states of VLA-4. J Biol Chem 268:228, 1993
31. Kovach NL, Carlos TM, Yee E, Harlan JM: A monoclonal antibody to β1 integrin (CD29) stimulates VLA-dependent adherence of leucocytes to human umbilical vein endothelial cells and matrix components. J Cell Biol 116:499, 1992
32. 1 subunit. J Cell Biol 117:659, 1992
33. van de Weil-van Kemenade E, van Kooyk Y, de Boer AJ, Huijbens RJF, Weder P, van de Kasteele W, Melief CJM, Figdor CG: Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the β subunit of VLA. J Cell Biol 117:461, 1992
34. 1) integrin receptors on T cells. Nature 345:250, 1990
35. 1 integrin-mediated lymphocyte adherence to extracellular matrix is enhanced by phorbol ester treatment. Eur J Immunol 21:517, 1991
36. Chan BMC, Wong JGP, Rao A, Hemler ME: T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol 147:398, 1991
37. 1-fibronectin receptors upon B cell activation. Eur J Immunol 21:2437, 1991
38. Hauzenberger D, Sundqvist KG: Fibronectin at the lymphocyte surface. Evidence for activation-dependent binding to VLA4 and VLA5 integrins. Scand J Immunol 37:87, 1993
39. Rot A: Endothelial cell binding of NAP-1/IL8: Role in neutrophil emigration. Immunol Today 13:291, 1992
40. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67:1033, 1991
41. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79, 1993
42. Huber AR, Kunkel SL, Todd RF, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99, 1991
43. Nathan C, Sporn M: Cytokines in context. J Cell Biol 113:981, 1991
44. Lo SK, Detmers PA, Levin SM, Wright SD: Transient adhesion of neutrophils to endothelium. J Exp Med 169:1779, 1989
45. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA: Neutrophil activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171:1155, 1990
46. Eaton JW, Skelton TD, Swofford HS, Kolpin CE, Jacob HS: Elevated erythrocyte calcium in sickle cell disease. Nature 246:105, 1973
47. Ramachandran M, Nair CN, Abraham EC: Increased membrane associated phorbol-12, 13 dibutyrate (PDBu) receptor function in sickle red cells. Biochem Biophys Res Commun 147:56, 1987
48. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745, 1973
49. Brittain HA: Adherence of sickle red cells to human micro-vascular endothelial versus umbilical vein endothelial cells; a role for plasma, von Willebrand factor and platelet thrombospondin, PhD Dissertation, Georgia Institute of Technology, Atlanta, GA, 1992
50. 1 interaction with connecting segment 1 and vascular cell adhesion molecule. J Biol Chem 269:18668, 1994
51. Hynes RO, Destree A: Extensive disulfide bonding at the mammalian cell surface. Proc Natl Acad Sci USA 74:2855, 1977
52. Keski-Oja J, Mosher DF, Vaheri A: Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun 74:699, 1977
53. Choi MG, Hynes RO: Biosynthesis and processing of fibronectin in NIL.8 hamster cells. J Biol Chem 254:12050, 1979
54. Oh E, Pierschbacher M, Ruoslahti E: Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci USA 78:3218, 1981
55. Sekiguchi K, Klos AM, Hirohashi S, Hakomori S: Human tissue fibronectin: Expression of different isotypes in the adult and fetal tissues. Biochem Biophys Res Commun 141:1012, 1986
56. McKeown-Longo PJ, Mosher DF: Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J Cell Biol 100:364, 1985
57. McDonald JA, Quade BJ, Broekelmann TJ, LaChance R, Forsman K, Hasegawa E, Akiyama S: Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J Biol Chem 262:2957, 1987
58. McKeown-Longo PJ, Mosher DF: Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol 97:466, 1983
59. 1) antibodies. J Cell Biol 111:699, 1990
60. Brass LF, Shattil SJ, Kunicki TJ, Bennett JS: Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem 260:7875, 1985
61. Fitzgerald LA, Phillips DR: Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem 260:11366, 1985
62. Hermanowski-Vosatka A, van Srtijp JA, Swiggard WJ, Wright SD: Integrin modulating factor-1: A lipid that alters the function of leukocyte integrins. Cell 68:341, 1992
63. Conforti G, Zanetti A, Pasquali-Ronchetti I, Quaglino D, Neyroz P, Dejana E: Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem 265:4011, 1990
64. Van Willigen G, Akkerman JW: Protein kinase C and cyclic AMP regulate the reversible exposure of binding sites for fibrinogen on the glycoprotein IIb-IIIa complex of human platelets. Biochem J 273:115, 1991
65. Chatila TA, Geha RS, Arnaout MA: Constitutive and stimulus induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol 109:3435, 1989
66. Buyon JP, Slade SG, Reibman J, Abramson SB, Phillips MR, Weissman G, Winchester R: Constitutive and induced phosphorylation of the a and β chains of CD11/CD18 leukocyte integrin family. J Immunol 144:191, 1990
67. Burn P, Kupfer A, Singer SJ: Dynamic membrane-cytoskeletal interactions: Specific association of integrin and talin arises in vivo after phorbol ester treatment of peripheral blood lymphocytes. Proc Natl Acad Sci USA 85:497, 1988
68. Pardi R, Inveradi L, Rugarli C, Bender JR: Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeletal association in T lymphocytes. J Cell Biol 116:1211, 1992
69. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617, 1991
70. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other defense cytokines. Proc Natl Acad Sci USA 84:9233, 1987
71. Walz A, Peveri P, Aschauer H, Baggiolini M: Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 149:755, 1987
72. Gregory H, Young J, Schroder JM, Mrowietz U, Chistophers E: Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun 151:883, 1988
73. Strieter RM, Phan SH, Schowell HJ, Remick DG, Lynch JP, Genord M, Raiford C, Eskandari M, Marks RM, Kunkel SL: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 264:10621, 1989
74. Strieter RM, Kunkel SL, Schowell HJ, Marks RM: Monokine-induced gene expression of a human endothelial cell derived neutrophil chemotactic factor. Biochem Biophys Res Commun 156:1340, 1988
75. Schroder JM, Chistophers E: Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 142:244, 1989
76. Jeannin P, Delneste Y, Gosset P, Molet S, Lassale P, Hamid Q, Tsicopoulos A, Tonnel AB: Histamine induces interleukin-8 secretion by endothelial cells. Blood 84:2229, 1994
77. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, Dinarello CA: Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84:4242, 1994
78. Lukacs NW, Strieter RM, Einer V, Evanoff HL, Burdick MD, Kunkel SL: Production of chemokines, interleukin-8, and monocyte chemoattractant protein-1 during monocyte:endothelial cell interactions. Blood 86:2767, 1995
79. Horuk R: The interleukin-8-receptor family: From chemokines to malaria. Immunol Today 15:169, 1994
80. Tilg H, Pape D, Trehu E, Shapiro L, Atkins MB, Dinarello CA, Mier JW: A method for detection of erythrocyte bound interleukin-8 in humans during interleukin-1 therapy. J Immunol Methods 163:253, 1993
81. Uguccioni M, Meliconi R, Nesci S, Lucarelli G, Ceska M, Gasbarrini G, Facchini A: Elevated interleukin-8 serum concentrations in β-thalassemia and graft-versus-host disease. Blood 81:2252, 1991
82. 1-mediated fibroblast migration on type-I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+. J Cell Biol 117:1109, 1992
83. Klug PP, Kay N, Jensen WN: Endothelial cell and vascular damage in sickle cell disorder. Blood Cells 8:175, 1982
84. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr: Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31:263, 1989
85. Blei F, Fancher T, Guarini L: Elevated levels of circulating molecules of potential endothelial origin in sickle cell disease. Blood 84:409a, 1994
86. Tanaka Y, Adams DH, Shaw S: Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14:111, 1993
87. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, Baker JB: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 88:1362, 1991
88. Neote K, Darbonne W, Ogez J, Horuk R, Schall T: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12247, 1993
89. Miller LH, Mason SJ, Dvorak JA, McGinnis MH, Rothman IK: Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189:561, 1975
90. Elices MJ, Tsai V, Strahl D, Goel AS, Tollefson V, Arrhenius T, Wayner EA, Gaeta FCA, Fikes JD, Firestein GS: Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 93:405, 1994